BioArctic & Eisai
15 shared events · Importance 6 · Last updated Sep 01, 2026
BioArctic is a research-based biopharma company that licenses its proprietary technologies and drug candidates, including Leqembi and BrainTransporter, to Eisai for global development and commercialization of Alzheimer's treatments.
Track how BioArctic and Eisai interact across events, view sentiment trends, and discover connected entities.
Open Dashboard